Holen Sie sich die Stockscreener-App
4.23
2.92%
0.12
Handel nachbörslich:
4.20
-0.03
-0.71%
Schlusskurs vom Vortag:
$4.11
Offen:
$4.09
24-Stunden-Volumen:
1.28M
Relative Volume:
0.94
Marktkapitalisierung:
$731.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-54.70M
KGV:
-12.82
EPS:
-0.33
Netto-Cashflow:
$-51.36M
1W Leistung:
+25.15%
1M Leistung:
+19.83%
6M Leistung:
+38.69%
1J Leistung:
+18.49%
1-Tages-Spanne:
$3.985
$4.25
1-Wochen-Bereich:
$3.38
$4.25
52-Wochen-Spanne:
$1.89
$4.295
Savara Inc Stock (SVRA) Company Profile
Firmenname
Savara Inc
Sektor
Branche
Telefon
51285113796
Adresse
6836 BEE CAVE ROAD, AUSTIN, TX
Vergleichen Sie SVRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
4.23 | 710.36M | 0 | -54.70M | -51.36M | -0.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.27 | 107.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
474.00 | 64.39B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
579.34 | 61.13B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
834.75 | 52.30B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.31 | 35.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Savara Inc Stock (SVRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-05-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-11-13 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-02-15 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-11-07 | Eingeleitet | Guggenheim | Buy |
| 2023-05-16 | Hochstufung | Jefferies | Hold → Buy |
| 2023-03-31 | Herabstufung | Jefferies | Buy → Hold |
| 2021-03-16 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-15 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-13 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-13 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2018-08-13 | Fortgesetzt | ROTH Capital | Neutral |
| 2018-01-03 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-09-27 | Fortgesetzt | ROTH Capital | Buy |
| 2017-09-22 | Eingeleitet | Jefferies | Buy |
| 2017-09-11 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Savara Inc Aktie (SVRA) Neueste Nachrichten
ROSEN, A LONGSTANDING LAW FIRM, Encourages Savara Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– SVRA - GlobeNewswire Inc.
Savara Inc. (SVRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
Savara (NASDAQ:SVRA) Coverage Initiated by Analysts at Wells Fargo & Company - Defense World
Aug EndMonth: How geopolitical risks impact Savara Inc. (YB4P) stockStop Loss & Weekly High Return Stock Forecasts - nchmf.gov.vn
Savara Inc. (SVRA) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 7, 2025 Deadline - ACCESS Newswire
How geopolitical risks impact Savara Inc. (YB4P) stockM&A Rumor & Accurate Intraday Trading Signals - nchmf.gov.vn
Shareholders SueWallSt in New Class Action Against Savara Inc.Act Now - ACCESS Newswire
Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit with a ... - Bluefield Daily Telegraph
Levi & Korsinsky Reminds Savara Inc. Investors of the - GlobeNewswire
Visual analytics tools that track Savara Inc. performanceLong Setup & Expert Verified Movement Alerts - newser.com
Deadline Alert: Savara Inc. (SVRA) Shareholders Who Lost - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers – SVRA - FinancialContent
Class Action Filed Against Savara Inc. (SVRA) Seeking Recovery for InvestorsContact The Gross Law Firm - Eastern Progress
Pattern recognition hints at Savara Inc. upsideWeekly Trading Summary & Verified Momentum Watchlists - newser.com
SVRA Investors Have Opportunity to Lead Savara Inc. Securities F - GuruFocus
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Savara Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsSVRA - MarketScreener
Class Action Filed Against Savara Inc. (SVRA) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Class Action Lawsuit Filed Against Savara Inc. (SVRA)Recover LossesContact Levi & Korsinsky Before November 7, 2025 - ACCESS Newswire
Why Savara Inc. is moving todayGap Up & Verified Stock Trade Ideas - newser.com
Is Savara Inc. stock recession proofJuly 2025 Gainers & Community Verified Trade Signals - nchmf.gov.vn
How analysts revise price targets for Savara Inc. (YB4P) stockJuly 2025 Technicals & High Accuracy Buy Signal Tips - nchmf.gov.vn
SAVARA CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urges Savara, Inc. Investors to ... - Bluefield Daily Telegraph
SAVARA CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain OfficersSVRA - WV News
Rate Hike: How analysts revise price targets for Savara Inc. (YB4P) stockCPI Data & Pattern Based Trade Signal System - nchmf.gov.vn
Why Savara Inc. stock could benefit from AI revolutionTrade Ideas & Short-Term High Return Strategies - nchmf.gov.vn
Savara promotes Yasmine Wasfi to chief medical officer By Investing.com - Investing.com Nigeria
SVRA Lead Plaintiff Deadline (11/7/25) Reminder: Savara Inc. Investors Should Contact Robbins LLP for Information About the Class Action Lawsuit - GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Q3 Earnings Forecast for Savara Issued By Lifesci Capital - Defense World
Savara promotes Yasmine Wasfi to chief medical officer - Investing.com
Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025SVRA - cnhinews.com
Savara promotes Wasfi to Chief Medical Officer - TipRanks
Savara Announces Chief Medical Officer (CMO) Transition - The Joplin Globe
Investors SueWallSt as Savara Inc. Faces Securities Fraud Allegations - ACCESS Newswire
Faruqi & Faruqi Reminds Savara Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025SVRA - FinancialContent
SVRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
SVRA LAWSUIT ALERT: The Gross Law Firm Notifies Savara Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - WV News
SVRA Shareholders Have Opportunity to Lead Savara Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
SVRA DEADLINE ALERT: Savara Inc. Investors Encouraged to - GlobeNewswire
SVRA DEADLINE ALERT: Savara Inc. Investors Encouraged to Contact Kirby McInerney LLP Before ... - Bluefield Daily Telegraph
Savara Inc. (SVRA) Shareholders Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages - GlobeNewswire
Savara, Inc.: A Deep Dive (NASDAQ:SVRA) - Seeking Alpha
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - Morningstar
SAVARA DEADLINE REMINDER: Bragar Eagel & Squire, P.C. - GlobeNewswire
Class Action Filed Against Savara Inc. (SVRA) Seeking Recovery for Investors – Contact The Gross Law Firm - GlobeNewswire
Lost Money on Savara Inc. (SVRA)? Join Class Action Before November 7, 2025Contact Levi & Korsinsky - ACCESS Newswire
November 7, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against SVRA - MarketScreener
Finanzdaten der Savara Inc-Aktie (SVRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.32%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):